Nationals rookie catcher Tres Barrera is suing Major League Baseball, a testing laboratory and its medical director after he was suspended 80 games without pay for testing positive for the alleged performance-enhancing drug Dehydrochlormethyltestosterone (DHCMT), The Washington Post’s Jesse Dougherty reported Monday.
Barrera lost an appeal of the decision last week but filed a lawsuit with the U.S. District Court for the Southern District of Texas on Monday. According to Dougherty, Barrera’s representation calls MLB’s designation of DHCMT as a performance-enhancing drug “junk science” and is seeking for Barrera to be allowed to return to the field while the case is being heard.
Dougherty also adds that the court file lists MLB, the Sports Medicine Research and Testing Laboratory and Dr. Daniel Eichner as defendants in the case. Dr. Eichner is the director of the Utah-based testing lab, which has been handling MLB’s entire COVID-19 testing program while the league attempts to put on a season amid the coronavirus pandemic.
The 25-year-old entered spring training and summer camp as a candidate for the Nationals’ third catcher job behind Kurt Suzuki and Yan Gomes. When the Nationals announced their Opening Day roster, Barrera appeared to lose out on the opportunity to fellow rookie Raudy Read—another Nationals catching prospect who was once suspended for PEDs, that time Boldenone.
Stay connected to the Nationals with the MyTeams app. Click here to download for comprehensive coverage of your teams.
MORE NATIONALS NEWS: